Lima M F, Kierszenbaum F
J Immunol. 1985 Jun;134(6):4176-83.
Mouse peritoneal macrophages (MPM) or human blood monocytes (HBM) co-cultured with intracellular (amastigote; AMA) forms of Trypanosoma cruzi in the presence of human lactoferrin (LF) took up greater numbers of organisms than in the absence of LF; the proportion of phagocytes taking up AMA was also significantly increased. Pretreatment of either MPM or AMA with LF also enhanced cell-parasite association. By immunofluorescence, HBM, MPM, and AMA were found to bind LF. By using 125I-labeled LF, each AMA was determined to have an average 1.1 X 10(6) surface receptors for LF. The enhancing effect of LF on cell-parasite association was inhibited when either rabbit anti-LF IgG or alpha-methyl mannoside (alpha-MM) was present during the incubation of MPM or AMA with LF, or when AMA pretreated with LF were then incubated with either of the LF blocking agents. Although these findings seemed to suggest that LF increased MPM-AMA association by bridging these cells, the LF effect was not inhibited when MPM pretreated with LF were subsequently incubated with either alpha-MM or anti-LF. Furthermore, LF stimulated phagocytosis, as denoted by a significant increase in latex particle uptake after LF treatment of MPM. The intracellular killing capacity of HBM or MPM was also stimulated by LF and was denoted by increased AMA destruction after LF treatments. The possibility that LF only appeared to increase the rate of AMA killing by simply promoting the engulfment of greater numbers of AMA that would then be destroyed intracellularly seemed unlikely because untreated MPM that had already taken up untreated AMA killed greater numbers of AMA when they were subsequently incubated with LF. The results of experiments with scavengers of oxygen reduction intermediates and of nitroblue tetrazolium reduction tests indicated that H2O2, O2- and 1O2 were involved in the killing of AMA by LF-treated MPM. These results suggest that LF, a glycoprotein secreted by neutrophils in greater than normal amounts during inflammation, may contribute to macrophage clearance of AMA released from infected host cells.
在人乳铁蛋白(LF)存在的情况下,与克氏锥虫胞内(无鞭毛体;AMA)形式共培养的小鼠腹腔巨噬细胞(MPM)或人血单核细胞(HBM)摄取的病原体数量比无LF时更多;摄取AMA的吞噬细胞比例也显著增加。用LF对MPM或AMA进行预处理也增强了细胞与寄生虫的结合。通过免疫荧光发现,HBM、MPM和AMA都能结合LF。使用125I标记的LF测定,每个AMA平均有1.1×10⁶个LF表面受体。当在MPM或AMA与LF孵育期间存在兔抗LF IgG或α-甲基甘露糖苷(α-MM)时,或者当用LF预处理的AMA随后与任何一种LF阻断剂孵育时,LF对细胞与寄生虫结合的增强作用受到抑制。尽管这些发现似乎表明LF通过桥接这些细胞增加了MPM-AMA的结合,但当用LF预处理的MPM随后与α-MM或抗LF孵育时,LF的作用并未受到抑制。此外,LF刺激吞噬作用,这表现为LF处理MPM后乳胶颗粒摄取显著增加。LF也刺激了HBM或MPM的细胞内杀伤能力,表现为LF处理后AMA破坏增加。LF似乎只是通过简单地促进吞噬更多随后在细胞内被破坏的AMA来增加AMA杀伤率,这种可能性似乎不大,因为已经摄取未处理AMA的未处理MPM在随后与LF孵育时会杀死更多的AMA。用氧还原中间体清除剂和硝基蓝四唑还原试验进行的实验结果表明,H₂O₂、O₂⁻和¹O₂参与了LF处理的MPM对AMA的杀伤。这些结果表明,LF是一种在炎症期间由中性粒细胞分泌量高于正常水平的糖蛋白,可能有助于巨噬细胞清除从受感染宿主细胞释放的AMA。